SCHEMBL12608697

SCHEMBL12608697

Cc1ccc2c(c1)c1cc([N+](=O)[O-])ccc1n2CCCN(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.50
▸ POLB P06746 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ CSF1R P07333 1/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ SIGMAR1 Q99720 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ DRD1 P21728 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12608625 0.94 MAPT (0.56) MAPTPOLBATMMEN1KMT2A
SCHEMBL12608706 0.88 MAPT (0.50) MAPTPOLBATMMEN1KMT2A
SCHEMBL11830811 0.88 MAPT (0.67) MAPTPOLBATMMEN1KMT2A
SCHEMBL11828899 0.86 MAPT (0.49) MAPTPOLBATMMEN1KMT2A
SCHEMBL12651170 0.84 MAPT (0.50) MAPTPOLBATMMEN1KMT2A
SCHEMBL15495623 0.82 MAPT (0.57) MAPTPOLBATMMEN1KMT2A
SCHEMBL12608702 0.82 MAPT (0.50) MAPTPOLBATMMEN1KMT2A
SCHEMBL12608626 0.81 MAPT (0.56) MAPTPOLBATMMEN1KMT2A
SCHEMBL12608704 0.81 SIGMAR1 (0.56) MAPTPOLBATMMEN1KMT2A
SCHEMBL11833660 0.80 MAPT (0.70) MAPTPOLBATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170165229-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, INC. 2017-06-15 — — US disclosed
US-9566265-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2017-02-14 — — US disclosed
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, INC. 2015-12-03 — — US disclosed
US-9108916-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2015-08-18 — — US disclosed
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS INCURON, LLC (US) 2014-10-09 — — US disclosed
US-8765738-B2 Carbazole compounds and therapeutic uses of the compounds INCURON, LLC (US) 2014-07-01 — — US disclosed
US-8486697-B2 Inducing cell death by inhibiting adaptive heat shock response INCURON, LLC (US) 2013-07-16 — — US disclosed
US-20110124104-A1 INDUCING CELL DEATH BY INHIBITING ADAPTIVE HEAT SHOCK RESPONSE INCURON, INC. 2011-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165229-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 MAPT 1792/4885POLB 779/4885ATM 1586/4885
US-20150342927-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 MAPT 1792/4885POLB 779/4885ATM 1586/4885
US-20140303224-A1 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE COMPOUNDS MALT1, PAICS, BCL9 MAPT 1792/4885POLB 779/4885ATM 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback